Skip to main content
OpenTrials
Completed

NCT Number: NCT02300740

Pharmacokinetic Analysis of Nicotinamide Riboside

Nicotinamide riboside is a newly discovered vitamin B3. The pharmacokinetics in humans is so far not analyzed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy Participants

Age range

18 year–30 year

Sex eligibility

Male

Study type

Interventional

Phase

Early Phase 1

Primary location

Medical Research Laboratories, Aarhus University Hospital

Aarhus, 8000, Denmark

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • BMI 18-25, healthy, male,

Exclusion criteria

  • liver or kidney diseases, other diseases

Treatment and study plan

Nicotinamide riboside

Dietary Supplement

NIAGEN, ChromaDex

Primary outcomes

  1. Serum nicotinamide riboside

    Time frame: 8 hours, blood samples every 15 min

Secondary outcomes

  1. serum concentrations of metabolites of nicotinamide riboside

    Time frame: 8 hour, blood samples every 15 min

  2. area under the curve for serum nicotinamide riboside

    Time frame: 8 hours, blood samples every 15 min

  3. calculation of halftime of serum nicotinamide riboside

    Time frame: 8 hours, blood samples every 15 min

  4. calculation of C-max of serum nicotinamide riboside

    Time frame: 8 hours, blood samples every 15 min

  5. calculation of t-max of serum nicotinamide riboside

    Time frame: 8 hours, blood samples every 15 min

Sponsors and collaborators

Lead sponsor

Aarhus University Hospital

Other

Collaborators

  • University of Copenhagen

Registry information

Important dates

Study start
2014
Primary completion
2015
First posted
Nov 25, 2014
Registry last updated
Feb 27, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.